BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23099097)

  • 1. Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities.
    Sipos A; Török Z; Rőth E; Kiss-Szikszai A; Batta G; Bereczki I; Fejes Z; Borbás A; Ostorházi E; Rozgonyi F; Naesens L; Herczegh P
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7092-6. PubMed ID: 23099097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of fluorescent ristocetin aglycon derivatives with remarkable antibacterial and antiviral activities.
    Sipos A; Máté G; Rőth E; Borbás A; Batta G; Bereczki I; Kéki S; Jóna I; Ostorházi E; Rozgonyi F; Vanderlinden E; Naesens L; Herczegh P
    Eur J Med Chem; 2012 Dec; 58():361-7. PubMed ID: 23149298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Click reaction synthesis of carbohydrate derivatives from ristocetin aglycon with antibacterial and antiviral activity.
    Pintér G; Bereczki I; Batta G; Otvös R; Sztaricskai F; Roth E; Ostorházi E; Rozgonyi F; Naesens L; Szarvas M; Boda Z; Herczegh P
    Bioorg Med Chem Lett; 2010 May; 20(9):2713-7. PubMed ID: 20381348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study.
    Pintér G; Batta G; Kéki S; Mándi A; Komáromi I; Takács-Novák K; Sztaricskai F; Röth E; Ostorházi E; Rozgonyi F; Naesens L; Herczegh P
    J Med Chem; 2009 Oct; 52(19):6053-61. PubMed ID: 19791806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
    Zu M; Yang F; Zhou W; Liu A; Du G; Zheng L
    Antiviral Res; 2012 Jun; 94(3):217-24. PubMed ID: 22521753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.
    Szűcs Z; Kelemen V; Le Thai S; Csávás M; Rőth E; Batta G; Stevaert A; Vanderlinden E; Naesens L; Herczegh P; Borbás A
    Eur J Med Chem; 2018 Sep; 157():1017-1030. PubMed ID: 30170320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-influenza activity of aminoalkyl rupestonates.
    Zhao J; Aisa HA
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2321-5. PubMed ID: 22341943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and biological investigation of thiazolylthioacetamides derivatives as a novel class of potential antiviral agents.
    Zhan P; Wang L; Liu H; Chen X; Li X; Jiang X; Zhang Q; Liu X; Pannecouque C; Naesens L; De Clercq E; Liu A; Du G
    Arch Pharm Res; 2012 Jun; 35(6):975-86. PubMed ID: 22870806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High molecular weight constituents of cranberry interfere with influenza virus neuraminidase activity in vitro.
    Oiknine-Djian E; Houri-Haddad Y; Weiss EI; Ofek I; Greenbaum E; Hartshorn K; Zakay-Rones Z
    Planta Med; 2012 Jun; 78(10):962-7. PubMed ID: 22588835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
    Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
    Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo investigations on the antiviral activity of a series of mixed-valence rare earth borotungstate heteropoly blues.
    Liu YN; Shi S; Mei WJ; Tan CP; Chen LM; Liu J; Zheng WJ; Ji LN
    Eur J Med Chem; 2008 Sep; 43(9):1963-70. PubMed ID: 18342405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.
    Zaraket H; Saito R; Wakim R; Tabet C; Medlej F; Reda M; Baranovich T; Suzuki Y; Dapat C; Caperig-Dapat I; Dbaibo GS; Suzuki H
    J Med Virol; 2010 Jul; 82(7):1224-8. PubMed ID: 20513088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial evaluation of some teicoplanin pseudoaglycon derivatives containing alkyl- and arylthiosubstituted maleimides.
    Csávás M; Miskovics A; Szűcs Z; Rőth E; Nagy ZL; Bereczki I; Herczeg M; Batta G; Nemes-Nikodém É; Ostorházi E; Rozgonyi F; Borbás A; Herczegh P
    J Antibiot (Tokyo); 2015 Sep; 68(9):579-85. PubMed ID: 25829202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of Antiviral Perfluoroalkyl Derivatives of Teicoplanin and Vancomycin.
    Bereczki I; Csávás M; Szűcs Z; Rőth E; Batta G; Ostorházi E; Naesens L; Borbás A; Herczegh P
    ChemMedChem; 2020 Sep; 15(17):1661-1671. PubMed ID: 32652783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
    Song JM; Park KD; Lee KH; Byun YH; Park JH; Kim SH; Kim JH; Seong BL
    Antiviral Res; 2007 Nov; 76(2):178-85. PubMed ID: 17709148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
    Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
    Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update: influenza activity - United States, September 28, 2008--January 31, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(5):115-9. PubMed ID: 19214161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies.
    Bereczki I; Kicsák M; Dobray L; Borbás A; Batta G; Kéki S; Nikodém ÉN; Ostorházi E; Rozgonyi F; Vanderlinden E; Naesens L; Herczegh P
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3251-4. PubMed ID: 24974341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update: influenza activity--United States, September 28-November 29, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(49):1329-32. PubMed ID: 19078922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
    Cheng H; Wan J; Lin MI; Liu Y; Lu X; Liu J; Xu Y; Chen J; Tu Z; Cheng YS; Ding K
    J Med Chem; 2012 Mar; 55(5):2144-53. PubMed ID: 22332894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.